Literature DB >> 23983153

Association of genetic variants in the IL4 and IL4R genes with the severity of joint damage in rheumatoid arthritis: a study in seven cohorts.

A Krabben1, A G Wilson, D P C de Rooy, A Zhernakova, E Brouwer, E Lindqvist, T Saxne, G Stoeken, J A B van Nies, R Knevel, T W J Huizinga, R Toes, P K Gregersen, A H M van der Helm-van Mil.   

Abstract

OBJECTIVE: The progression of joint destruction in rheumatoid arthritis (RA) is determined by genetic factors. Changes in IL4 and IL4R genes have been associated with RA severity, but this finding has not been replicated. This study was undertaken to investigate the association between IL4- and IL4R-tagging single-nucleotide polymorphisms (SNPs) and the progression rate of joint damage in RA in a multicohort candidate gene study.
METHODS: IL4- and IL4R-tagging SNPs (n = 8 and 39, respectively) were genotyped in 600 RA patients for whom 2,846 sets of radiographs of the hands and feet were obtained during 7 years of followup. Subsequently, SNPs significantly associated with the progression of joint damage were genotyped and studied in relation to 3,415 radiographs of 1,953 RA patients; these included data sets from Groningen (The Netherlands), Lund (Sweden), Sheffield (UK), the North American Rheumatoid Arthritis Consortium (US), Wichita (US), and the National Data Bank (US). The relative increase in progression rate per year in the presence of a genotype was determined in each cohort. An inverse variance weighting meta-analysis was performed on the 6 data sets that together formed the replication phase.
RESULTS: In the discovery phase, none of the IL4 SNPs and 7 of the IL4R SNPs were significantly associated with the joint damage progression rate. In the replication phase, 2 SNPs in the IL4R gene were significantly associated with the joint damage progression rate (rs1805011 [P = 0.02] and rs1119132 [P = 0.001]).
CONCLUSION: Genetic variants in IL4R were identified, and their association with the progression rate of joint damage in RA was independently replicated.
Copyright © 2013 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23983153     DOI: 10.1002/art.38141

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

1.  C5orf30 is a negative regulator of tissue damage in rheumatoid arthritis.

Authors:  Munitta Muthana; Sarah Hawtree; Adam Wilshaw; Eimear Linehan; Hannah Roberts; Sachin Khetan; Gbadebo Adeleke; Fiona Wright; Mohammed Akil; Ursula Fearon; Douglas Veale; Barbara Ciani; Anthony G Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-27       Impact factor: 11.205

2.  Do Genetic Susceptibility Variants Associate with Disease Severity in Early Active Rheumatoid Arthritis?

Authors:  Ian C Scott; Frühling Rijsdijk; Jemma Walker; Jelmar Quist; Sarah L Spain; Rachael Tan; Sophia Steer; Yukinori Okada; Soumya Raychaudhuri; Andrew P Cope; Cathryn M Lewis
Journal:  J Rheumatol       Date:  2015-05-15       Impact factor: 4.666

3.  A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis.

Authors:  Hanna W van Steenbergen; Luis Rodríguez-Rodríguez; Ewa Berglin; Alexandra Zhernakova; Rachel Knevel; Jose Ivorra-Cortés; Tom W J Huizinga; Benjamin Fernández-Gutiérrez; Peter K Gregersen; Solbritt Rantapää-Dahlqvist; Annette H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2015-01-08       Impact factor: 5.156

Review 4.  Genetics of rheumatoid arthritis susceptibility, severity, and treatment response.

Authors:  Sebastien Viatte; Anne Barton
Journal:  Semin Immunopathol       Date:  2017-05-29       Impact factor: 9.623

5.  Functionality and opposite roles of two interleukin 4 haplotypes in immune cells.

Authors:  G Anovazzi; M C Medeiros; S C Pigossi; L S Finoti; T M Souza Moreira; M P A Mayer; C F Zanelli; S R Valentini; C Rossa-Junior; R M Scarel-Caminaga
Journal:  Genes Immun       Date:  2017-01-05       Impact factor: 2.676

6.  Anti-inflammatory Mechanism of Geniposide: Inhibiting the Hyperpermeability of Fibroblast-Like Synoviocytes via the RhoA/p38MAPK/NF-κB/F-Actin Signal Pathway.

Authors:  Ran Deng; Feng Li; Hong Wu; Wen-Yu Wang; Li Dai; Zheng-Rong Zhang; Jun Fu
Journal:  Front Pharmacol       Date:  2018-02-15       Impact factor: 5.810

7.  Long non-coding RNA PVT1 knockdown suppresses fibroblast-like synoviocyte inflammation and induces apoptosis in rheumatoid arthritis through demethylation of sirt6.

Authors:  Chun-Wang Zhang; Xia Wu; Dan Liu; Wei Zhou; Wei Tan; Yu-Xuan Fang; Yu Zhang; Yan-Qing Liu; Guo-Qing Li
Journal:  J Biol Eng       Date:  2019-07-02       Impact factor: 4.355

8.  The effects of gene polymorphisms in interleukin-4 and interleukin-6 on the susceptibility of rheumatoid arthritis in a Chinese population.

Authors:  Xiang Li; Wei Chai; Ming Ni; Meng Xu; Zijian Lian; Lewis Shi; Yang Bai; Yan Wang
Journal:  Biomed Res Int       Date:  2014-02-23       Impact factor: 3.411

9.  Association Between Genetic Variation in FOXO3 and Reductions in Inflammation and Disease Activity in Inflammatory Polyarthritis.

Authors:  Sebastien Viatte; James C Lee; Bo Fu; Marion Espéli; Mark Lunt; Jack N E De Wolf; Lily Wheeler; John A Reynolds; Madhura Castelino; Deborah P M Symmons; Paul A Lyons; Anne Barton; Kenneth G C Smith
Journal:  Arthritis Rheumatol       Date:  2016-11       Impact factor: 10.995

10.  IL-4Rα Polymorphism Is Associated With Myasthenia Gravis in Chinese Han Population.

Authors:  Ping Jiang; Yao-Xian Yue; Yu Hong; Yanchen Xie; Xiang Gao; Chuan-Kai Gu; Hong-Jun Hao; Yue Qin; Xiao-Jun Ding; Min Song; Hai-Feng Li; Xu Zhang
Journal:  Front Neurol       Date:  2018-07-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.